Search - tctmd.com

Displaying 141 - 160 of 626

Sort: Relevancy | Date

Presentation

Time to Cost-Effectiveness After Stroke Reduction Strategies in A-fib: Warfarin vs Novel Oral Anticoagulants (NOACs) vs Left Atrial Appendage (LAA) Closure

Presenter: Vivek Y. Reddy

December 13, 2015

News Daily News

Societies Issue Recommendations for Operators, Institutions Offering LAA Closure Procedures

L.A. McKeown

December 10, 2015

News Daily News

Las Sociedades Publican Recomendaciones para que Operadores y Centros Ofrezcan Intervenciones para el Cierre del AAI

L.A. McKeown

December 10, 2015

News Industry News

Praxbind® (idarucizumab) approved in European Union for the specific reversal of Pradaxa® (dabigatran etexilate)

November 29, 2015

News Daily News

Un Meta Análisis Avala el Mayor Uso del Abordaje Radial

November 29, 2015

News Daily News

Meta-Analysis Boosts Case for Increased Use of Radial Access

November 29, 2015

News Daily News

Does the Watchman LAA Occluder Reduce Bleeding?

L.A. McKeown

November 25, 2015

News Daily News

New Findings on Bioprosthetic Valve Thrombosis Have Implications for Surveillance, Research

Caitlin E. Cox

November 23, 2015

News Daily News

Nuevos Hallazgos sobre la Trombosis de la Válvula Bioprotésica Tienen Implicaciones en Materia de Vigilancia e Investigación

Caitlin E. Cox

November 23, 2015

News Industry News

Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device

November 19, 2015

News Opinion Editor's Corner

My Takeaways From AHA 2015

Shelley Wood

November 18, 2015

News Daily News

Good News, Bad News Week for Watchman LAA Occluder

Shelley Wood

November 12, 2015

News Conference News AHA 2015

Reversal Agents Safely Stop Effects of Novel Oral Anticoagulants

Yael L. Maxwell

November 10, 2015

News Conference News AHA 2015

DAPT Score Provides ‘Personalized Medicine’ Tool for Determining Whether to Extend Therapy Beyond 1 Year

Yael L. Maxwell

November 09, 2015

News Daily News

Endovascular Therapy Beats Thrombolysis for Improving Function After Stroke

L.A. McKeown

November 03, 2015

News Daily News

El Tratamiento Endovascular Supera a la Trombolisis Mejorando la Funcionalidad Post-ACV

L.A. McKeown

November 03, 2015

News Daily News

NEJM Endorses Robert Califf for FDA Commissioner

L.A. McKeown

October 30, 2015

News Daily News

NEJM Apoya a Robert Califf como Comisionado de la FDA

L.A. McKeown

October 30, 2015

News Daily News

首个 NOAC 逆转剂 Idarucizumab 获批；不太可能耽误介入治疗

Todd Neale

October 26, 2015

News Daily News

First NOAC Antidote, Idarucizumab, Approved; Likely Won’t Hold Up Interventions

Todd Neale

October 26, 2015

Advertisement

Time to Cost-Effectiveness After Stroke Reduction Strategies in A-fib: Warfarin vs Novel Oral Anticoagulants (NOACs) vs Left Atrial Appendage (LAA) Closure

Societies Issue Recommendations for Operators, Institutions Offering LAA Closure Procedures

Las Sociedades Publican Recomendaciones para que Operadores y Centros Ofrezcan Intervenciones para el Cierre del AAI

Praxbind® (idarucizumab) approved in European Union for the specific reversal of Pradaxa® (dabigatran etexilate)

Un Meta Análisis Avala el Mayor Uso del Abordaje Radial

Meta-Analysis Boosts Case for Increased Use of Radial Access

Does the Watchman LAA Occluder Reduce Bleeding?

New Findings on Bioprosthetic Valve Thrombosis Have Implications for Surveillance, Research

Nuevos Hallazgos sobre la Trombosis de la Válvula Bioprotésica Tienen Implicaciones en Materia de Vigilancia e Investigación

Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device

My Takeaways From AHA 2015

Good News, Bad News Week for Watchman LAA Occluder

Reversal Agents Safely Stop Effects of Novel Oral Anticoagulants

DAPT Score Provides ‘Personalized Medicine’ Tool for Determining Whether to Extend Therapy Beyond 1 Year

Endovascular Therapy Beats Thrombolysis for Improving Function After Stroke

El Tratamiento Endovascular Supera a la Trombolisis Mejorando la Funcionalidad Post-ACV

NEJM Endorses Robert Califf for FDA Commissioner

NEJM Apoya a Robert Califf como Comisionado de la FDA

首个 NOAC 逆转剂 Idarucizumab 获批；不太可能耽误介入治疗

First NOAC Antidote, Idarucizumab, Approved; Likely Won’t Hold Up Interventions

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content